NYSE:TBI - Trueblue Stock Price, Price Target & More

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Trueblue declared that its Board of Directors has initiated a stock buyback plan on Tuesday, October 31st 2017, which allows the company to repurchase $100,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its stock is undervalued.

Trueblue Inc (NYSE:TBI) posted its quarterly earnings data on Monday, April, 30th. The business services provider reported $0.31 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.22 by $0.09. The business services provider had revenue of $554.39 million for the quarter, compared to analysts' expectations of $570.40 million. Trueblue had a return on equity of 13.81% and a net margin of 2.39%. The business's quarterly revenue was down 2.4% compared to the same quarter last year. During the same period last year, the business posted $0.21 EPS. View Trueblue's Earnings History.

Trueblue is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Trueblue.

Trueblue updated its second quarter earnings guidance on Monday, April, 30th. The company provided earnings per share (EPS) guidance of $0.47-0.53 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.53. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $627.25 million.

2 brokerages have issued 12 month target prices for Trueblue's stock. Their forecasts range from $26.00 to $29.00. On average, they anticipate Trueblue's stock price to reach $27.50 in the next year. This suggests a possible upside of 0.2% from the stock's current price. View Analyst Ratings for Trueblue.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Trueblue include ASGN (ASGN), Insperity (NSP), Dometic Group AB (publ) (DTCGF), AMN Healthcare Services (AMN), TTEC (TTEC), Kforce (KFRC), Kelly Services, Inc. Class B (KELYB), Kelly Services, Inc. Class A (KELYA), Barrett Business Services (BBSI), SThree (STREF), Cross Country Healthcare (CCRN), StarTek (SRT), DLH (DLHC), R C M Technologies (RCMT) and Hudson Global (HSON).

News headlines about TBI stock have been trending positive on Wednesday, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Trueblue earned a media sentiment score of 0.29 on Accern's scale. They also assigned news articles about the business services provider an impact score of 46.29 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Trueblue's stock is owned by many different of retail and institutional investors. Top institutional investors include Bank of Montreal Can (0.29%) and Alpha Windward LLC (0.05%). Company insiders that own Trueblue stock include Bonnie W Soodik, Derrek Lane Gafford, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Institutional Ownership Trends for Trueblue.

TBI stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can. Company insiders that have sold Trueblue company stock in the last year include Bonnie W Soodik, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Insider Buying and Selling for Trueblue.

TBI stock was purchased by a variety of institutional investors in the last quarter, including Alpha Windward LLC. View Insider Buying and Selling for Trueblue.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $27.45.

Trueblue has a market capitalization of $1.10 billion and generates $2.51 billion in revenue each year. The business services provider earns $55.45 million in net income (profit) each year or $1.74 on an earnings per share basis. Trueblue employs 5,500 workers across the globe.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]